These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7296919)

  • 1. [Fundamental investigation of estradiol-3N-bis-(2-chloroethyl) carbamate-17 beta-phosphate (Estracyt)-on the antiprostatic effect of this drug (author's transl)].
    Yamanaka H; Koya J; Imai K; Nakai K; Yuasa H
    Horumon To Rinsho; 1981 Apr; 29(4):477-85. PubMed ID: 7296919
    [No Abstract]   [Full Text] [Related]  

  • 2. Incorporation of 3H-thymidine and 14C-amino acids into the ventral prostate after in vivo treatment with estradiol-3N-BIS(2-chloroethyl)carbamate-17 beta-phosphate (Estracyt) and its estrogen and cytostatic parts.
    Hoisaeter PA
    Invest Urol; 1976 Sep; 14(2):85-92. PubMed ID: 972011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of oestradiol-3N-bis-(2-chloroethyl)carbamate-17beta-phosphate (estracyt) on the 5alpha-reductase in the rat ventral prostate.
    Hoisaeter PA
    Acta Endocrinol (Copenh); 1975 Sep; 80(1):188-98. PubMed ID: 1173982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone-induced DNA synthesis in cultured rat ventral prostate: effects of estracyt and its derivatives.
    Buchanan LJ; Riches AC
    Br J Cancer; 1987 Jan; 55(1):47-51. PubMed ID: 3814475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacology and metabolism of a new therapeutic drug for prostatic cancer "Estracyt"].
    Yamanaka H; Shida K
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):537-44. PubMed ID: 6422861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of estracyt on the rat prostate.
    Yamanaka H; Shimazaki J; Imai K; Sugiyama Y; Shida K
    Invest Urol; 1977 Mar; 14(5):400-4. PubMed ID: 845006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estramustine phosphate (Estracyt): experimental and clinical studies in Europe.
    Hoisaeter PA; Bakke A
    Semin Oncol; 1983 Sep; 10(3 Suppl 3):27-33. PubMed ID: 6364363
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of a steroidal alkylating agent (estramustine phosphate) in rat ventral prostate.
    Høisaeter PA
    Scand J Urol Nephrol Suppl; 1977; (46):1-72. PubMed ID: 279091
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical studies on serum lipids in the patients with tumor of the prostate gland. 2nd. Report. Changes of serum lipids and lipoprotein fractions during the treatment of estramustine phosphate disodium, hexestrol and diethylstilbestrol 4, 4-diphosphoric ester for the patients with prostatic cancer (author's transl)].
    Yoshida H; Shimada M
    Nihon Hinyokika Gakkai Zasshi; 1980 Jan; 71(1):59-69. PubMed ID: 6155501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the antiprostatic action of estracyt, a nitrogen mustard of estradiol.
    Kirdani RY; Müntzing J; Varkarakis MJ; Murphy GP; Sandberg AA
    Cancer Res; 1974 May; 34(5):1031-7. PubMed ID: 4823900
    [No Abstract]   [Full Text] [Related]  

  • 11. Uptake in vivo of 45Ca in male accessory sex organs of the rat: effect of estramustine phosphate and diethylstilbestrol diphosphate.
    Batra S; Müntzing J
    Eur J Pharmacol; 1981 Nov; 76(1):87-91. PubMed ID: 7318924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrotubule effects of estramustine, an antiprostatic tumor drug.
    Stearns ME; Tew KD
    Cancer Res; 1985 Aug; 45(8):3891-7. PubMed ID: 4016756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition by estramustine phosphate on estradiol and androgen binding in benign and malignant prostate in humans.
    Nilsson I; Liskowski L; Nilsson T
    Urology; 1976 Aug; 8(2):118-21. PubMed ID: 60819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of drug-vinyl copolymer delivery composites on the rat prostate.
    Yoshida M; Asano M; Kaetsu I; Yamanaka H; Nakai K; Yuasa H; Shida K
    J Biomed Mater Res; 1985; 19(6):615-29. PubMed ID: 2416759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiprostatic effects of a nitrogen mustard of estriol.
    Varkarakis MJ; Kirdani RY; Murphy GP; Sandberg AA
    Proc Soc Exp Biol Med; 1975 Mar; 148(3):904-8. PubMed ID: 1129313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug information. Estramustini phophas (Estracyt)].
    Helsingborg/Lundbeck L
    Ugeskr Laeger; 1975 Sep; 137(38):2203-4. PubMed ID: 1166562
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction of the cytotoxic agent estramustine phosphate (Estracyt) with the estrogen receptor of the human uterus.
    Muechler EK; Kohler D
    Gynecol Oncol; 1979 Dec; 8(3):330-8. PubMed ID: 510999
    [No Abstract]   [Full Text] [Related]  

  • 18. Binding characteristics of a major protein in rat ventral prostate cytosol that interacts with estramustine, a nitrogen mustard derivative of 17 beta-estradiol.
    Forsgren B; Gustafsson JA; Pousette A; Högberg B
    Cancer Res; 1979 Dec; 39(12):5155-64. PubMed ID: 40694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of estramustine and megestrol on ultrastructure of rat ventral prostate.
    Dinchuk JE; Chai LS; Karr JP; Murphy GP; Sandberg AA
    Urology; 1982 May; 19(5):511-22. PubMed ID: 7080325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Estracyt (estradiol-nitrogen mustard complex)--estramustine binding protein and its specificity].
    Yamanaka H; Imai K; Suzuki T; Yuasa H; Takahashi E
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2106-14. PubMed ID: 6486830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.